文献速递其他结缔组织病

系统性硬化症中的抗线粒体抗体靶向肠神经元并与胃肠道动力障碍相关

Antimitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility.
PubMed 文献 · Ann Rheum Dis · 2025-06-27

在154例系统性硬化症(SSc)患者中筛查抗线粒体M2自身抗体(AM2A),147例可评估者中19例(12.9%)阳性;AM2A阳性与食管转运变慢(β -14.4,95%CI -26.2,-2.6)和胃转运变慢(β -7.9,95%CI -14.1,-1.6)显著相关。体外实验显示SSc血清自身抗体可穿透活细胞并靶向线粒体M2抗原,AM2A穿透HepG2细胞后改变细胞呼吸,提示其可能致病。

要点

  • 147例SSc患者中19例(12.9%)AM2A阳性。
  • AM2A阳性与食管转运变慢(β -14.4,95%CI -26.2,-2.6)和胃转运变慢(β -7.9,95%CI -14.1,-1.6)显著相关。
  • SSc-AM2A可在体外穿透活细胞并靶向线粒体M2抗原,穿透HepG2细胞后改变细胞呼吸。

核心结论

  • SSc患者中的AM2A与胃肠道转运变慢相关。
  • SSc自身抗体可在体外穿透活细胞,SSc-AM2A穿透活细胞靶向线粒体M2抗原并造成功能缺陷。
  • 部分肠神经元(MENS)富含线粒体且在体外可被SSc-AM2A穿透,携带AM2A的SSc患者出现胃肠道动力障碍提示SSc-AM2A可能在体内穿透MENS,驱动肠神经系统和胃肠道功能障碍。
  • 需进一步研究以检验AM2A如何在体内改变肠神经系统功能从而参与SSc胃肠道动力障碍。

研究设计与样本

  • 研究纳入154例特征明确的SSc患者,采用酶联免疫吸附试验筛查血清AM2A。
  • 比较AM2A阳性与AM2A阴性患者的临床特征和胃肠道转运数据。
  • 将HepG2细胞与这些血清共培养并用AM2A共染色。
  • 在成人小鼠含肌间神经丛的纵行肌组织和HepG2细胞培养中加入SSc血清,观察自身抗体穿透活细胞。
  • 采用Seahorse检测评估SSc-AM2A穿透HepG2细胞后细胞呼吸的变化。

主要发现

  • 147例可评估患者中19例(12.9%)为AM2A阳性。
  • AM2A阳性与食管转运变慢显著相关(β -14.4,95%CI -26.2,-2.6)。
  • AM2A阳性与胃转运变慢显著相关(β -7.9,95%CI -14.1,-1.6)。
  • 免疫染色显示泛线粒体抗原TOM-20和M2在人肠神经系统神经元中富集,尤其在中胚层来源的肠神经元(MENS)中。
  • SSc血清中的自身抗体在成人小鼠含肌间神经丛的纵行肌组织和HepG2细胞与SSc血清共培养时穿透活的成人小鼠MENS和HepG2细胞,穿透后AM2A定位于线粒体,免疫沉淀显示与M2抗原结合。

局限性

  • 需进一步研究以检验AM2A如何在体内改变肠神经系统功能从而参与SSc胃肠道动力障碍。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Most patients with systemic sclerosis (SSc) experience gastrointestinal (GI) dysmotility. The enteric nervous system (ENS) regulates GI motility, and its dysfunction causes dysmotility. A subset of SSc patients harbour antimitochondrial M2 autoantibodies (AM2A). Here, we investigate whether M2 is expressed by specific ENS cells, and if AM2A are associated with GI dysmotility in SSc patients. METHODS: Sera from 154 well-characterised patients with SSc were screened for AM2A by enzyme-linked immunosorbent assay. Clinical features and GI transit data were compared between AM2A-positive and AM2A-negative patients. Hepatocellular carcinoma cell line 2 (HepG2) cells were cultured with these sera and costained with AM2A. RESULTS: Nineteen of 147 patients (12.9%) were AM2A-positive. AM2A positivity was significantly associated with slower transit in the oesophagus (β -14.4, 95%CI, -26.2, -2.6) and stomach (β -7.9, 95% CI, -14.1, -1.6). Immunostaining demonstrated pan-mitochondrial antigens TOM-20 and M2 enrichment in human ENS neurons, specifically in mesoderm-derived enteric neurons (MENS). Autoantibodies in SSc sera penetrated live adult murine MENs and HepG2 cells when adult murine longitudinal muscle containing myenteric plexus tissue and HepG2 cells were cultured in the presence of SSc sera. Upon penetrating live cells, AM2A localised to mitochondria, and immunoprecipitation demonstrated binding to the M2 antigen. Seahorse assays show that penetration of HepG2 cells with SSc-AM2A altered cellular respiration suggesting that penetrating AM2A is pathogenic. CONCLUSIONS: AM2A in SSc patients are associated with slower GI transit. SSc autoantibodies penetrate live cells in vitro, and SSc-AM2A penetrates live cells to target the mitochondrial M2 antigen and cause functional deficits. Because a subset of enteric neurons (MENs) is enriched in mitochondria, which are similarly penetrated by SSc-AM2A in vitro, the presence of GI dysmotility in SSc patients harbouring AM2A suggests that SSc-AM2A may penetrate MENs in vivo, driving ENS and GI dysfunction. Further studies are warranted to test how AM2A alter ENS functions in vivo to contribute to GI dysmotility in SSc.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. McMahan ZH, Puttapaka SN, Casciola-Rosen L, et al. Antimitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility. Ann Rheum Dis. 2025. PMID: 40581581. doi:10.1016/j.ard.2025.06.2119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。